Panacea Biotec Ltd.
•₹ 411.1-0.62%
2026-08-21
PROS
- Latest quarter profit grew 120.7% YoY, showing strong momentum
- Operating margins have improved to -2.2% from -25.4%
- Institutional investors have been accumulating - FII+DII up 2.3pp
CONS
- Company is loss-making at the operating / net level
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on equity of -9.1% over last 3 years
- Company has a low return on capital employed of -3.1%
- Interest coverage is weak at -0.7x - earnings barely cover interest
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.26x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | PANACEABIO | 402.75 | 0.00 | 2466.87 | 0.00 | 2.20 | -44.44 | 199.57 | 19.72 | -0.47 | 2.84 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89 | 95 | 95 | 80 | 57 | 77 | 108 | 68 | 112 | 91 | 99 | 111 | 135 | |
| 83 | 85 | 89 | 90 | 67 | 70 | 93 | 86 | 115 | 105 | 101 | 111 | 139 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 3 | 2 | 3 | 16 | 4 | 3 | 3 | 6 | 5 | 4 | 4 | 6 | 6 |
| Interest | 3 | 4 | 3 | 3 | 3 | 4 | 4 | 5 | 6 | 6 | 7 | 6 | 7 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| 1 | 3 | 1 | -1 | -15 | 1 | 10 | -22 | -9 | -21 | -9 | -5 | 2 | |
| Tax % | 0.00% | 0.00% | 59.81% | -1.48% | 8.01% | 0.77% | 0.00% | 43.76% | 24.21% | 25.27% | 22.28% | 96.10% | 30.50% |
| Net Profit | 1 | 3 | 0 | -1 | -14 | 1 | 10 | -12 | -7 | -16 | -7 | -0 | 1 |
| 0 | 1 | 0 | -0 | -2 | 0 | 2 | -2 | -1 | -3 | -1 | -0 | 0 | |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 89
- 83
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 3
- Depreciation
- 5
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 95
- 85
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 4
- Depreciation
- 5
- 3
- Tax %
- 0.00%
- Net Profit
- 3
- 1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 95
- 89
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 3
- Depreciation
- 5
- 1
- Tax %
- 59.81%
- Net Profit
- 0
- 0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 80
- 90
- Operating Profit
- —
- OPM %
- —
- Other Income
- 16
- Interest
- 3
- Depreciation
- 5
- -1
- Tax %
- -1.48%
- Net Profit
- -1
- -0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 57
- 67
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 3
- Depreciation
- 5
- -15
- Tax %
- 8.01%
- Net Profit
- -14
- -2
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 77
- 70
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 4
- Depreciation
- 5
- 1
- Tax %
- 0.77%
- Net Profit
- 1
- 0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 108
- 93
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 4
- Depreciation
- 5
- 10
- Tax %
- 0.00%
- Net Profit
- 10
- 2
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 68
- 86
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 5
- Depreciation
- 5
- -22
- Tax %
- 43.76%
- Net Profit
- -12
- -2
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 112
- 115
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 6
- Depreciation
- 5
- -9
- Tax %
- 24.21%
- Net Profit
- -7
- -1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 91
- 105
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 6
- Depreciation
- 5
- -21
- Tax %
- 25.27%
- Net Profit
- -16
- -3
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 99
- 101
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 7
- Depreciation
- 5
- -9
- Tax %
- 22.28%
- Net Profit
- -7
- -1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 111
- 111
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 6
- Depreciation
- 4
- -5
- Tax %
- 96.10%
- Net Profit
- -0
- -0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 135
- 139
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 7
- Depreciation
- 4
- 2
- Tax %
- 30.50%
- Net Profit
- 1
- 0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 647 | 530 | 574 | 444 | 490 | 344 | 236 | 257 | 360 | 310 | 436 | |
| 534 | 461 | 493 | 591 | 480 | 343 | 308 | 320 | 345 | 317 | 455 | |
| Operating Profit | 138 | 123 | 99 | -138 | 54 | 21 | -60 | -28 | 39 | 10 | — |
| OPM % | 21 | 23 | 17 | -31 | 11 | 6 | -26 | -11 | 11 | 3 | — |
| Other Income | 26 | 54 | 18 | 8 | 44 | 21 | 13 | 34 | 25 | 17 | 19 |
| Interest | 115 | 104 | 103 | 105 | 147 | 8 | 7 | 10 | 14 | 15 | 26 |
| Depreciation | 71 | 66 | 57 | 54 | 27 | 27 | 26 | 24 | 21 | 20 | 18 |
| 1 | -84 | -61 | 37 | -136 | -13 | -94 | -63 | 4 | -26 | -33 | |
| Tax % | 38 | 14 | -17 | 29 | -13 | -12 | 0 | -40 | 16 | 42 | 34 |
| Net Profit | 1 | -73 | -72 | 27 | -153 | -14 | -94 | -88 | 4 | -15 | -22 |
| EPS | 0 | 0 | 0 | 0 | 0 | -2 | -15 | -14 | 1 | -2 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | -12 | -12 | 4 | -25 | -2 | -15 | -14 | 1 | -2 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | -12 | -12 | 4 | -25 | -2 | -15 | -14 | 1 | -2 | — |
Mar 2016
- 647
- 534
- Operating Profit
- 138
- OPM %
- 21
- Other Income
- 26
- Interest
- 115
- Depreciation
- 71
- 1
- Tax %
- 38
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2017
- 530
- 461
- Operating Profit
- 123
- OPM %
- 23
- Other Income
- 54
- Interest
- 104
- Depreciation
- 66
- -84
- Tax %
- 14
- Net Profit
- -73
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2018
- 574
- 493
- Operating Profit
- 99
- OPM %
- 17
- Other Income
- 18
- Interest
- 103
- Depreciation
- 57
- -61
- Tax %
- -17
- Net Profit
- -72
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2019
- 444
- 591
- Operating Profit
- -138
- OPM %
- -31
- Other Income
- 8
- Interest
- 105
- Depreciation
- 54
- 37
- Tax %
- 29
- Net Profit
- 27
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2020
- 490
- 480
- Operating Profit
- 54
- OPM %
- 11
- Other Income
- 44
- Interest
- 147
- Depreciation
- 27
- -136
- Tax %
- -13
- Net Profit
- -153
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -25
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -25
Mar 2021
- 344
- 343
- Operating Profit
- 21
- OPM %
- 6
- Other Income
- 21
- Interest
- 8
- Depreciation
- 27
- -13
- Tax %
- -12
- Net Profit
- -14
- EPS
- -2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -2
Mar 2022
- 236
- 308
- Operating Profit
- -60
- OPM %
- -26
- Other Income
- 13
- Interest
- 7
- Depreciation
- 26
- -94
- Tax %
- 0
- Net Profit
- -94
- EPS
- -15
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -15
Mar 2023
- 257
- 320
- Operating Profit
- -28
- OPM %
- -11
- Other Income
- 34
- Interest
- 10
- Depreciation
- 24
- -63
- Tax %
- -40
- Net Profit
- -88
- EPS
- -14
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -14
Mar 2024
- 360
- 345
- Operating Profit
- 39
- OPM %
- 11
- Other Income
- 25
- Interest
- 14
- Depreciation
- 21
- 4
- Tax %
- 16
- Net Profit
- 4
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 310
- 317
- Operating Profit
- 10
- OPM %
- 3
- Other Income
- 17
- Interest
- 15
- Depreciation
- 20
- -26
- Tax %
- 42
- Net Profit
- -15
- EPS
- -2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -2
TTM
- 436
- 455
- Operating Profit
- —
- OPM %
- —
- Other Income
- 19
- Interest
- 26
- Depreciation
- 18
- -33
- Tax %
- 34
- Net Profit
- -22
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- -8%
- 5 Years:
- -9%
- 3 Years:
- 10%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 14%
- 5 Years:
- 6%
- 3 Years:
- 46%
- 1 Year:
- 1%
RETURN ON EQUITY
- 10 Years:
- -11%
- 5 Years:
- -10%
- 3 Years:
- -9%
- Last Year:
- -5%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |
| 518 | 450 | 382 | 412 | 855 | 502 | 409 | 320 | 323 | 308 | |
| 218 | 308 | 399 | 600 | 7 | 3 | 0 | 0 | 0 | 68 | |
| Trade Payables | 174 | 227 | 242 | 78 | 136 | 124 | 145 | 129 | 116 | 165 |
| 1,062 | 929 | 793 | 496 | 304 | 327 | 373 | 441 | 480 | 334 | |
| Total Liabilities | 1,978 | 1,920 | 1,822 | 1,593 | 1,307 | 962 | 933 | 895 | 925 | 881 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 988 | 942 | 891 | 496 | 447 | 398 | 416 | 385 | 357 | 348 | |
| Capital Work in Progress | 9 | 6 | 5 | 3 | 4 | 13 | 1 | 16 | 71 | 87 |
| 395 | 345 | 345 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | |
| 137 | 141 | 149 | 43 | 99 | 87 | 129 | 116 | 108 | 152 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 21 | |
| Cash & Bank | 9 | 7 | 12 | 8 | 61 | 89 | 43 | 43 | 12 | 62 |
| 441 | 479 | 420 | 1,041 | 694 | 374 | 344 | 334 | 366 | 210 | |
| Total Assets | 1,978 | 1,920 | 1,822 | 1,593 | 1,307 | 962 | 933 | 895 | 925 | 881 |
| Total Debt | 1,019 | 1,023 | 970 | 689 | 67 | 65 | 84 | 102 | 125 | 228 |
| Net Working Capital | -133 | -181 | -332 | -5 | 447 | 58 | 5 | -52 | -66 | -58 |
| Contingent Liabilities | 354 | 364 | 379 | 404 | 367 | 407 | 368 | 656 | 369 | 367 |
| Book Value per Share | 18.54 | 74.42 | 63.36 | 68.32 | 140.53 | 82.97 | 67.77 | 53.17 | 53.74 | 51.26 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 1,019 | 1,023 | 970 | 689 | 67 | 65 | 84 | 102 | 125 | 228 |
| Net Working Capital | -133 | -181 | -332 | -5 | 447 | 58 | 5 | -52 | -66 | -58 |
| Contingent Liabilities | 354 | 364 | 379 | 404 | 367 | 407 | 368 | 656 | 369 | 367 |
| Book Value per Share | 18.54 | 74.42 | 63.36 | 68.32 | 140.53 | 82.97 | 67.77 | 53.17 | 53.74 | 51.26 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2016
- 6
- 518
- 218
- Trade Payables
- 174
- 1,062
- Total Liabilities
- 1,978
- 988
- Capital Work in Progress
- 9
- 395
- 137
- 0
- Cash & Bank
- 9
- 441
- Total Assets
- 1,978
- Total Debt
- 1,019
- Net Working Capital
- -133
- Contingent Liabilities
- 354
- Book Value per Share
- 18.54
- Face Value
- 1.00
- Total Debt
- 1,019
- Net Working Capital
- -133
- Contingent Liabilities
- 354
- Book Value per Share
- 18.54
- Face Value
- 1.00
Mar 2017
- 6
- 450
- 308
- Trade Payables
- 227
- 929
- Total Liabilities
- 1,920
- 942
- Capital Work in Progress
- 6
- 345
- 141
- 0
- Cash & Bank
- 7
- 479
- Total Assets
- 1,920
- Total Debt
- 1,023
- Net Working Capital
- -181
- Contingent Liabilities
- 364
- Book Value per Share
- 74.42
- Face Value
- 1.00
- Total Debt
- 1,023
- Net Working Capital
- -181
- Contingent Liabilities
- 364
- Book Value per Share
- 74.42
- Face Value
- 1.00
Mar 2018
- 6
- 382
- 399
- Trade Payables
- 242
- 793
- Total Liabilities
- 1,822
- 891
- Capital Work in Progress
- 5
- 345
- 149
- 0
- Cash & Bank
- 12
- 420
- Total Assets
- 1,822
- Total Debt
- 970
- Net Working Capital
- -332
- Contingent Liabilities
- 379
- Book Value per Share
- 63.36
- Face Value
- 1.00
- Total Debt
- 970
- Net Working Capital
- -332
- Contingent Liabilities
- 379
- Book Value per Share
- 63.36
- Face Value
- 1.00
Mar 2019
- 6
- 412
- 600
- Trade Payables
- 78
- 496
- Total Liabilities
- 1,593
- 496
- Capital Work in Progress
- 3
- 3
- 43
- 0
- Cash & Bank
- 8
- 1,041
- Total Assets
- 1,593
- Total Debt
- 689
- Net Working Capital
- -5
- Contingent Liabilities
- 404
- Book Value per Share
- 68.32
- Face Value
- 1.00
- Total Debt
- 689
- Net Working Capital
- -5
- Contingent Liabilities
- 404
- Book Value per Share
- 68.32
- Face Value
- 1.00
Mar 2020
- 6
- 855
- 7
- Trade Payables
- 136
- 304
- Total Liabilities
- 1,307
- 447
- Capital Work in Progress
- 4
- 3
- 99
- 0
- Cash & Bank
- 61
- 694
- Total Assets
- 1,307
- Total Debt
- 67
- Net Working Capital
- 447
- Contingent Liabilities
- 367
- Book Value per Share
- 140.53
- Face Value
- 1.00
- Total Debt
- 67
- Net Working Capital
- 447
- Contingent Liabilities
- 367
- Book Value per Share
- 140.53
- Face Value
- 1.00
Mar 2021
- 6
- 502
- 3
- Trade Payables
- 124
- 327
- Total Liabilities
- 962
- 398
- Capital Work in Progress
- 13
- 0
- 87
- 0
- Cash & Bank
- 89
- 374
- Total Assets
- 962
- Total Debt
- 65
- Net Working Capital
- 58
- Contingent Liabilities
- 407
- Book Value per Share
- 82.97
- Face Value
- 1.00
- Total Debt
- 65
- Net Working Capital
- 58
- Contingent Liabilities
- 407
- Book Value per Share
- 82.97
- Face Value
- 1.00
Mar 2022
- 6
- 409
- 0
- Trade Payables
- 145
- 373
- Total Liabilities
- 933
- 416
- Capital Work in Progress
- 1
- 0
- 129
- 0
- Cash & Bank
- 43
- 344
- Total Assets
- 933
- Total Debt
- 84
- Net Working Capital
- 5
- Contingent Liabilities
- 368
- Book Value per Share
- 67.77
- Face Value
- 1.00
- Total Debt
- 84
- Net Working Capital
- 5
- Contingent Liabilities
- 368
- Book Value per Share
- 67.77
- Face Value
- 1.00
Mar 2023
- 6
- 320
- 0
- Trade Payables
- 129
- 441
- Total Liabilities
- 895
- 385
- Capital Work in Progress
- 16
- 0
- 116
- 0
- Cash & Bank
- 43
- 334
- Total Assets
- 895
- Total Debt
- 102
- Net Working Capital
- -52
- Contingent Liabilities
- 656
- Book Value per Share
- 53.17
- Face Value
- 1.00
- Total Debt
- 102
- Net Working Capital
- -52
- Contingent Liabilities
- 656
- Book Value per Share
- 53.17
- Face Value
- 1.00
Mar 2024
- 6
- 323
- 0
- Trade Payables
- 116
- 480
- Total Liabilities
- 925
- 357
- Capital Work in Progress
- 71
- 0
- 108
- 11
- Cash & Bank
- 12
- 366
- Total Assets
- 925
- Total Debt
- 125
- Net Working Capital
- -66
- Contingent Liabilities
- 369
- Book Value per Share
- 53.74
- Face Value
- 1.00
- Total Debt
- 125
- Net Working Capital
- -66
- Contingent Liabilities
- 369
- Book Value per Share
- 53.74
- Face Value
- 1.00
Mar 2025
- 6
- 308
- 68
- Trade Payables
- 165
- 334
- Total Liabilities
- 881
- 348
- Capital Work in Progress
- 87
- 0
- 152
- 21
- Cash & Bank
- 62
- 210
- Total Assets
- 881
- Total Debt
- 228
- Net Working Capital
- -58
- Contingent Liabilities
- 367
- Book Value per Share
- 51.26
- Face Value
- 1.00
- Total Debt
- 228
- Net Working Capital
- -58
- Contingent Liabilities
- 367
- Book Value per Share
- 51.26
- Face Value
- 1.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 98 | 104 | 172 | 107 | -83 | 38 | -53 | -11 | 33 | 4 | |
| Cash from Investing | 23 | -18 | -3 | -8 | -19 | -37 | 40 | 2 | -47 | -61 |
| Cash from Financing | -129 | -91 | -164 | -98 | 109 | -7 | 10 | 9 | 13 | 90 |
| -8 | -5 | 6 | 0 | 8 | -6 | -3 | 1 | -1 | 33 | |
| Free Cash Flow | 98 | 88 | 168 | 107 | -83 | 38 | -79 | -13 | 4 | -22 |
| OCF / Net Profit | 112.47 | -1.43 | -2.39 | 4.03 | 0.54 | -2.65 | 0.56 | 0.12 | 9.32 | -0.26 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 378 | 318 | 151 | -30 | -133 | -73 |
| OCF / Net Profit | 112.47 | -1.43 | -2.39 | 4.03 | 0.54 | -2.65 | 0.56 | 0.12 | 9.32 | -0.26 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 378 | 318 | 151 | -30 | -133 | -73 |
Mar 2016
- 98
- Cash from Investing
- 23
- Cash from Financing
- -129
- -8
- Free Cash Flow
- 98
- OCF / Net Profit
- 112.47
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 112.47
- Cumulative 5-Year FCF
- 0
Mar 2017
- 104
- Cash from Investing
- -18
- Cash from Financing
- -91
- -5
- Free Cash Flow
- 88
- OCF / Net Profit
- -1.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.43
- Cumulative 5-Year FCF
- 0
Mar 2018
- 172
- Cash from Investing
- -3
- Cash from Financing
- -164
- 6
- Free Cash Flow
- 168
- OCF / Net Profit
- -2.39
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.39
- Cumulative 5-Year FCF
- 0
Mar 2019
- 107
- Cash from Investing
- -8
- Cash from Financing
- -98
- 0
- Free Cash Flow
- 107
- OCF / Net Profit
- 4.03
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 4.03
- Cumulative 5-Year FCF
- 0
Mar 2020
- -83
- Cash from Investing
- -19
- Cash from Financing
- 109
- 8
- Free Cash Flow
- -83
- OCF / Net Profit
- 0.54
- Cumulative 5-Year FCF
- 378
- OCF / Net Profit
- 0.54
- Cumulative 5-Year FCF
- 378
Mar 2021
- 38
- Cash from Investing
- -37
- Cash from Financing
- -7
- -6
- Free Cash Flow
- 38
- OCF / Net Profit
- -2.65
- Cumulative 5-Year FCF
- 318
- OCF / Net Profit
- -2.65
- Cumulative 5-Year FCF
- 318
Mar 2022
- -53
- Cash from Investing
- 40
- Cash from Financing
- 10
- -3
- Free Cash Flow
- -79
- OCF / Net Profit
- 0.56
- Cumulative 5-Year FCF
- 151
- OCF / Net Profit
- 0.56
- Cumulative 5-Year FCF
- 151
Mar 2023
- -11
- Cash from Investing
- 2
- Cash from Financing
- 9
- 1
- Free Cash Flow
- -13
- OCF / Net Profit
- 0.12
- Cumulative 5-Year FCF
- -30
- OCF / Net Profit
- 0.12
- Cumulative 5-Year FCF
- -30
Mar 2024
- 33
- Cash from Investing
- -47
- Cash from Financing
- 13
- -1
- Free Cash Flow
- 4
- OCF / Net Profit
- 9.32
- Cumulative 5-Year FCF
- -133
- OCF / Net Profit
- 9.32
- Cumulative 5-Year FCF
- -133
Mar 2025
- 4
- Cash from Investing
- -61
- Cash from Financing
- 90
- 33
- Free Cash Flow
- -22
- OCF / Net Profit
- -0.26
- Cumulative 5-Year FCF
- -73
- OCF / Net Profit
- -0.26
- Cumulative 5-Year FCF
- -73
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 0.14 | -11.86 | -11.73 | 4.34 | -24.99 | -2.35 | -15.28 | -14.29 | 0.58 | -2.49 |
| Book Value (₹) | 18.54 | 74.42 | 63.36 | 68.32 | 140.53 | 82.97 | 67.77 | 53.17 | 53.74 | 51.26 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 11.78 | -1.06 | -2.42 | 13.11 | -20.54 | 1.98 | -10.96 | -10.29 | 4.02 | 0.83 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 21.33% | 22.64% | 17.15% | -31.18% | 10.55% | 6.10% | -25.43% | -10.90% | 3.93% | -2.23% |
| Net Margin % | 0.13% | -13.36% | -12.44% | 5.98% | -29.92% | -4.14% | -39.60% | -33.84% | 0.98% | -4.89% |
| ROE % | 0.77% | -25.52% | -17.03% | 6.59% | -23.93% | -2.11% | -20.27% | -23.64% | 1.08% | -4.74% |
| ROCE % | 10.15% | 1.48% | 2.96% | 11.51% | 1.09% | -0.70% | -16.14% | -11.36% | 4.08% | -2.13% |
| 0.04% | -3.73% | -3.84% | 1.56% | -10.56% | -1.27% | -9.88% | -9.57% | 0.39% | -1.69% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 68 | 107 | 101 | 69 | 15 | 28 | 45 | 25 | 12 | 19 |
| Inventory Days | 78 | 93 | 92 | 79 | 51 | 98 | 167 | 173 | 113 | 152 |
| Payable Days | 307 | 433 | 434 | 325 | 259 | 269 | 438 | 307 | 316 | 499 |
| -160 | -233 | -242 | -177 | -193 | -144 | -226 | -109 | -191 | -328 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 7.84x | 2.24x | 2.50x | 1.65x | 0.08x | 0.13x | 0.20x | 0.31x | 0.38x | 0.73x |
| Interest Coverage (x) | 1.01x | 0.19x | 0.41x | 1.36x | 0.08x | -0.71x | -12.29x | -5.24x | 1.31x | -0.69x |
| 0.72x | 0.69x | 0.52x | 0.99x | 3.67x | 1.29x | 1.02x | 0.79x | 0.74x | 0.84x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -4.76% | -18.06% | 8.32% | -22.64% | 10.25% | -29.84% | -31.45% | 9.16% | 39.89% | -13.83% |
| Operating Profit Growth % | 44.47% | -10.81% | -19.57% | -239.83% | 138.96% | -60.64% | -383.02% | 53.09% | 238.60% | -75.21% |
| Net Profit Growth % | 101.33% | -8451.84% | 1.08% | 136.97% | -676.10% | 90.58% | -549.25% | 6.45% | 104.06% | -528.93% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 104.06% | -528.92% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 209.28x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.26x | 8.60x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 21.90x | 295.78x |
Mar 2016
- EPS (₹)
- 0.14
- Book Value (₹)
- 18.54
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 11.78
- Operating Margin %
- 21.33%
- Net Margin %
- 0.13%
- ROE %
- 0.77%
- ROCE %
- 10.15%
- 0.04%
- Debtor Days
- 68
- Inventory Days
- 78
- Payable Days
- 307
- -160
- Debt to Equity (x)
- 7.84x
- Interest Coverage (x)
- 1.01x
- 0.72x
- Revenue Growth %
- -4.76%
- Operating Profit Growth %
- 44.47%
- Net Profit Growth %
- 101.33%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- -11.86
- Book Value (₹)
- 74.42
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -1.06
- Operating Margin %
- 22.64%
- Net Margin %
- -13.36%
- ROE %
- -25.52%
- ROCE %
- 1.48%
- -3.73%
- Debtor Days
- 107
- Inventory Days
- 93
- Payable Days
- 433
- -233
- Debt to Equity (x)
- 2.24x
- Interest Coverage (x)
- 0.19x
- 0.69x
- Revenue Growth %
- -18.06%
- Operating Profit Growth %
- -10.81%
- Net Profit Growth %
- -8451.84%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- -11.73
- Book Value (₹)
- 63.36
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -2.42
- Operating Margin %
- 17.15%
- Net Margin %
- -12.44%
- ROE %
- -17.03%
- ROCE %
- 2.96%
- -3.84%
- Debtor Days
- 101
- Inventory Days
- 92
- Payable Days
- 434
- -242
- Debt to Equity (x)
- 2.50x
- Interest Coverage (x)
- 0.41x
- 0.52x
- Revenue Growth %
- 8.32%
- Operating Profit Growth %
- -19.57%
- Net Profit Growth %
- 1.08%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 4.34
- Book Value (₹)
- 68.32
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.11
- Operating Margin %
- -31.18%
- Net Margin %
- 5.98%
- ROE %
- 6.59%
- ROCE %
- 11.51%
- 1.56%
- Debtor Days
- 69
- Inventory Days
- 79
- Payable Days
- 325
- -177
- Debt to Equity (x)
- 1.65x
- Interest Coverage (x)
- 1.36x
- 0.99x
- Revenue Growth %
- -22.64%
- Operating Profit Growth %
- -239.83%
- Net Profit Growth %
- 136.97%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -24.99
- Book Value (₹)
- 140.53
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -20.54
- Operating Margin %
- 10.55%
- Net Margin %
- -29.92%
- ROE %
- -23.93%
- ROCE %
- 1.09%
- -10.56%
- Debtor Days
- 15
- Inventory Days
- 51
- Payable Days
- 259
- -193
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- 0.08x
- 3.67x
- Revenue Growth %
- 10.25%
- Operating Profit Growth %
- 138.96%
- Net Profit Growth %
- -676.10%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -2.35
- Book Value (₹)
- 82.97
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.98
- Operating Margin %
- 6.10%
- Net Margin %
- -4.14%
- ROE %
- -2.11%
- ROCE %
- -0.70%
- -1.27%
- Debtor Days
- 28
- Inventory Days
- 98
- Payable Days
- 269
- -144
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- -0.71x
- 1.29x
- Revenue Growth %
- -29.84%
- Operating Profit Growth %
- -60.64%
- Net Profit Growth %
- 90.58%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -15.28
- Book Value (₹)
- 67.77
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -10.96
- Operating Margin %
- -25.43%
- Net Margin %
- -39.60%
- ROE %
- -20.27%
- ROCE %
- -16.14%
- -9.88%
- Debtor Days
- 45
- Inventory Days
- 167
- Payable Days
- 438
- -226
- Debt to Equity (x)
- 0.20x
- Interest Coverage (x)
- -12.29x
- 1.02x
- Revenue Growth %
- -31.45%
- Operating Profit Growth %
- -383.02%
- Net Profit Growth %
- -549.25%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -14.29
- Book Value (₹)
- 53.17
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -10.29
- Operating Margin %
- -10.90%
- Net Margin %
- -33.84%
- ROE %
- -23.64%
- ROCE %
- -11.36%
- -9.57%
- Debtor Days
- 25
- Inventory Days
- 173
- Payable Days
- 307
- -109
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- -5.24x
- 0.79x
- Revenue Growth %
- 9.16%
- Operating Profit Growth %
- 53.09%
- Net Profit Growth %
- 6.45%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.58
- Book Value (₹)
- 53.74
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.02
- Operating Margin %
- 3.93%
- Net Margin %
- 0.98%
- ROE %
- 1.08%
- ROCE %
- 4.08%
- 0.39%
- Debtor Days
- 12
- Inventory Days
- 113
- Payable Days
- 316
- -191
- Debt to Equity (x)
- 0.38x
- Interest Coverage (x)
- 1.31x
- 0.74x
- Revenue Growth %
- 39.89%
- Operating Profit Growth %
- 238.60%
- Net Profit Growth %
- 104.06%
- 104.06%
- P/E (x)
- 209.28x
- P/B (x)
- 2.26x
- Dividend Yield %
- 0.00%
- 21.90x
Mar 2025
- EPS (₹)
- -2.49
- Book Value (₹)
- 51.26
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.83
- Operating Margin %
- -2.23%
- Net Margin %
- -4.89%
- ROE %
- -4.74%
- ROCE %
- -2.13%
- -1.69%
- Debtor Days
- 19
- Inventory Days
- 152
- Payable Days
- 499
- -328
- Debt to Equity (x)
- 0.73x
- Interest Coverage (x)
- -0.69x
- 0.84x
- Revenue Growth %
- -13.83%
- Operating Profit Growth %
- -75.21%
- Net Profit Growth %
- -528.93%
- -528.92%
- P/E (x)
- 0.00x
- P/B (x)
- 8.60x
- Dividend Yield %
- 0.00%
- 295.78x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-18 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication
- Copy of Newspaper Publication
2026-08-14 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.